<?xml version="1.0" encoding="UTF-8"?>
<root>
    <author>ENA</author>
    <category>Sectors</category>
    <date>2025-02-11 18:07:55</date>
    <fulldesc>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;strong&gt;New Delhi, Feb 11 (KNN)&lt;/strong&gt; Indias pharmaceutical industry is on the brink of remarkable growth, with its global market share projected to rise to 5 per cent by 2030, according to a report by Bain &amp;amp; Company.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Currently valued at around USD 55 billion, the Indian pharma market is expected to more than double over the next six years, reaching an estimated USD 120 billion to USD 130 billion.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;By 2047, the market could approach USD 450 billion, cementing Indias position as a major player in the global pharmaceutical landscape.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;At present, the global pharmaceutical industry is valued at about USD 1.6 trillion, with India contributing roughly 3 per cent to 3.5 per cent. What makes Indias pharma sector unique is that its export market is as substantial as its domestic market.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Pharmaceutical exports, a vital component of Indias economy, accounted for 6 per cent of total merchandise exports by value in 2023.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;These exports grew significantly from USD 19 billion in 2018 to USD 27 billion in 2023, marking an 8 per cent annual growth rate.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;More than 70% of Indias pharmaceutical exports consist of formulations, with bulk drugs and drug intermediates making up another 20 per cent.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Other export categories include vaccines, biosimilars, and innovative products like New Chemical Entities (NCEs) and New Biological Entities (NBEs).&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;India has become a global hub, housing over 10,000 manufacturing facilities and more than 3,000 pharmaceutical companies, including 650 US-FDA-compliant plants   the highest outside the U.S.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Indian pharma products reach nearly 200 countries, meeting around 50 per cent of Africa's demand for generics and 40 per cent of the U.S. needs.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Despite being the worlds largest supplier of generic medicines, India ranks only 11th in terms of export value, accounting for 3 per cent of global pharmaceutical exports.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;Nevertheless, strong domestic demand, a booming export market, and ongoing innovations signal a promising future for Indias pharmaceutical sector.&lt;/span&gt;&lt;/p&gt;&#13;
&#13;
&lt;p&gt;&lt;em&gt;&lt;strong&gt;&lt;span style=&quot;font-size:14px&quot;&gt;(KNN Bureau)&lt;/span&gt;&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;&#13;
</fulldesc>
    <id>41029</id>
    <link>https://knnindia.co.in/news/newsdetails/sectors/indias-pharmaceutical-industry-on-track-to-reach-usd-130-billion</link>
    <pubDate>2025-02-11 18:07:55</pubDate>
    <source>knnindia.co.in</source>
    <title>India’s Pharmaceutical Industry on Track to Reach USD 130 Billion</title>
</root>
